Inactive Instrument

All News Novelion Therapeutics Inc Nasdaq

Equities

CA7469271026

End-of-day quote Nasdaq Other stock markets
- ^USD	-

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

QLT : Dividends, Mergers, and Study Results - Analyst Notes on Pfizer, Gilead, Pacira, QLT and Agenus	01/14/01	PR
QLT Inc. : Valeant Pharmaceuticals Acquires Visudyne® From QLT	24/12/24	PR
QLT INC : QLT Announces Issuance of U.S. Patent for Use of QLT091001 in Treatment of Inherited or Age-Related Retinal Diseases	31/11/31	PU
QLT INC : QLT Inc. establishes sales force in the United States	22/09/22	PR
QLT INC : QLT initiates Phase Ib study of QLT091001 in Leber Congenital Amaurosis	15/09/15	PR
QLT INC : 6-month results from EVEREST study evaluating Visudyne(R) therapy in patients with polypoidal choroidal vasculopathy	09/09/09	PR
QLT INC : QLT announces MGH litigation settlement	25/09/25	PR
QLT INC : QLT announces Toronto Stock Exchange approval of share repurchase program	29/09/29	PR
QLT INC : QLT Announces Share Repurchase Program	27/09/27	PR
QLT INC : QLT announces third quarter results for 2009	27/09/27	PR
QLT INC : QLT restructures Visudyne(R) agreement	19/09/19	PR
QLT INC : QLT announces sale of QLT USA, Inc. for up to US$230 million	02/09/02	PR
QLT INC : QLT announces receipt of a CDN$45.3 million tax refund	08/09/08	PR
QLT INC : QLT Announces Second Quarter Results for 2009	28/09/28	PR
QLT INC : QLT announces interim data from a Phase II clinical trial and a device study for the Punctal Plug Drug Delivery System	28/09/28	PR
QLT INC COM NPV : QLT announces 12-month results from Novartis sponsored MONT BLANC study evaluating standard-fluence Visudyne(R) combination therapy	15/09/15	PR
QLT : announces positive results from the evaluation of Visudyne(R) combination therapy	02/09/02	PR
QLT : Announces Court Response to Motion to Dismiss and Removal of Case to Federal Court	22/09/22	PR
QLT : announces first quarter results for 2009	28/09/28	PR
QLT : names Kathryn Falberg to the board of directors	26/09/26	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Novelion Therapeutics Inc Nasdaq

Equities

CA7469271026

All News

Filters